NuVasive (NUVA) PT Raised to $72 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Brean Capital Raises Price Target on NuVasive (NUVA) to $70 Following Solid 2Q
July 27, 2016 11:04 AM EDTBrean Capital reiterated a Buy rating on NuVasive (NASDAQ: NUVA), and raised the price target to $70.00 (from $60.00), following the company's 2Q earnings report.
Analyst Jason Wittes commented, "NUVA reported a 16.4% (16.1% cc) revenue increase to $236.2 millionabove consensus and our $233.0 million estimate and was strong... More
NuVasive (NUVA) Tops Q2 EPS by 4c; Guides Abovce
July 26, 2016 4:05 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $236.5 million versus the consensus estimate of $233.01 million.
GUIDANCE:
NuVasive sees FY2016 EPS of $1.64, versus the consensus of $1.51. NuVasive sees FY2016 revenue... More
